|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.94 USD | -1.02% |
|
-2.51% | -2.02% |
ProQR Therapeutics N.V. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was EUR 0.655 million compared to EUR 1.13 million a year ago. Net loss was EUR 8.93 million compared to EUR 14.11 million a year ago.
Basic loss per share from continuing operations was EUR 0.11 compared to EUR 0.2 a year ago. Diluted loss per share from continuing operations was EUR 0.11 compared to EUR 0.2 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.02% | 158M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
PROQR THERAPEUTICS N.V. 
